Nordsjællands Hospital, Hillerød, Onkologisk Afdeling

Hillerød 3400

0 studies enrolling now · 2 studies all time

What they study most

Breast Cancer, Non-Squamous Non-Small Cell Lung Cancer

Studies at this site

• A Study of Pertuzumab in Addition to Chemotherapy and Trastuzumab as Adjuvant Therapy in Participants With Human Epidermal Growth Receptor 2 (HER2)-Positive Primary Breast Cancer — Completed
• A Study of Bevacizumab in Combination With Standard of Care Treatment in Participants With Advanced Non-squamous Non-small Cell Lung Cancer (NSCLC) — Completed